Side effects track the pharmacokinetics
UK Availability At present, retatrutide is not approved for prescription or retail use in the UK
Tirzepatide microdose protocol: Starting at 0.5 mg weekly, holding for 4 to 6 weeks, with similar marker-based reassessment
But in reality, choosing the better option is a fine balance between maximum weight loss potency, real-world availability, and what your body can actually tolerate
Results vary depending on metabolism, lifestyle factors, and consistency with treatment
3 Clinical evidence No direct head-to-head trial Theres no clinical trial that directly compared oral semaglutide (Rybelsus) to injectable semaglutide (Ozempic)